TODD STRATEGY GROUP

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Jul 12, 2026

Lobbying activity 2

Health Issues

Alzheimer's Disease. Anti Obesity Medication.

Medicare/Medicaid

Medicare/Medicaid Coverage and Reimbursement. PDUFA. 340B Program. Issues related to drug compounding.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.